CAM

Cormorant Asset Management Portfolio holdings

AUM $1.76B
1-Year Est. Return 415.22%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+415.22%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$3.47B
AUM Growth
+$32.8M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
127
New
Increased
Reduced
Closed

Top Buys

1
+$173M
2
+$75.9M
3
+$49.8M
4
RXDX
Prometheus Biosciences, Inc. Common Stock
RXDX
+$43.3M
5
TPTX
Turning Point Therapeutics, Inc. Common Stock
TPTX
+$42.5M

Top Sells

1
+$71.6M
2
+$51.4M
3
+$32.3M
4
CRSP icon
CRISPR Therapeutics
CRSP
+$30.6M
5
KURA icon
Kura Oncology
KURA
+$21.2M

Sector Composition

1 Healthcare 96.94%
2 Financials 0.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
101
$2.42M 0.07%
422,167
102
$2.41M 0.07%
+130,000
103
$2.26M 0.07%
427,975
104
$1.93M 0.06%
+125,000
105
$1.86M 0.05%
25,665
106
$1.39M 0.04%
150,000
107
$1.39M 0.04%
20,000
108
$895K 0.03%
3,466
109
$824K 0.02%
10,000
110
$772K 0.02%
23,437
111
$584K 0.02%
25,000
112
$563K 0.02%
133,331
113
$421K 0.01%
+416,666
114
$400K 0.01%
1,333
-1,334
115
$222K 0.01%
+83,332
116
– –
-650,000
117
– –
0
118
– –
0
119
– –
0
120
– –
0
121
– –
-20,336
122
– –
-2,600,000
123
– –
-1,429,200
124
– –
-250,000
125
– –
-500,000
2 3 4
5
6